Search research articles
Contact Us
Filters
Showing results (11-20 of 450) with videos related to
Page
of 45
Sort By:
Gut
|
February 1, 2024
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
Alexander C Ford
Gastroenterology
|
April 28, 2012
Eradicating Helicobacter pylori in functional dyspepsia
Alexander C Ford
Evidence-Based Medicine
|
March 24, 2012
In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents
Alexander C Ford
The Lancet. Gastroenterology & Hepatology
|
November 5, 2017
Stool as a treatment for IBS: more questions than answers?
Alexander C Ford
Gut
|
August 24, 2010
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease
Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 5, 2015
Is it Time to Rethink Screening of Individuals With Symptoms of Irritable Bowel Syndrome for Celiac Disease?
Alexander C Ford
Gut
|
January 10, 2015
Aetiopathogenesis of functional dyspepsia
Alexander C Ford
Gastroenterology & Hepatology
|
May 26, 2021
Overlap Between Irritable Bowel Syndrome and Inflammatory Bowel Disease
Alexander C Ford
Gastroenterology
|
September 22, 2018
Intending to Treat Patients With Irritable Bowel Syndrome With Cognitive-Behavioral Therapy
Alexander C Ford
Gastroenterology
|
January 30, 2013
First-line eradication therapy for Helicobacter pylori: time for a change?
Alexander C Ford
Page
of 45
Search research articles
Search
Showing results (11-20 of 450) with videos related to
Sort By:
Page
of 45
Gut
|
February 1, 2024
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
Alexander C Ford
Gastroenterology
|
April 28, 2012
Eradicating Helicobacter pylori in functional dyspepsia
Alexander C Ford
Evidence-Based Medicine
|
March 24, 2012
In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents
Alexander C Ford
The Lancet. Gastroenterology & Hepatology
|
November 5, 2017
Stool as a treatment for IBS: more questions than answers?
Alexander C Ford
Gut
|
August 24, 2010
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease
Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 5, 2015
Is it Time to Rethink Screening of Individuals With Symptoms of Irritable Bowel Syndrome for Celiac Disease?
Alexander C Ford
Gut
|
January 10, 2015
Aetiopathogenesis of functional dyspepsia
Alexander C Ford
Gastroenterology & Hepatology
|
May 26, 2021
Overlap Between Irritable Bowel Syndrome and Inflammatory Bowel Disease
Alexander C Ford
Gastroenterology
|
September 22, 2018
Intending to Treat Patients With Irritable Bowel Syndrome With Cognitive-Behavioral Therapy
Alexander C Ford
Gastroenterology
|
January 30, 2013
First-line eradication therapy for Helicobacter pylori: time for a change?
Alexander C Ford
Page
of 45